DD150352A5 - Verfahren zur herstellung von antibiotikum 7 beta-[d-[carboxy-(4-hydroxyphenyl)acetyl]-7alpha-methoxy-3-[[(1-methyl-1h-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-azabicyclo[4.1.0]-oct-2-en-2-carbonsaenrediammoniumsalz - Google Patents

Verfahren zur herstellung von antibiotikum 7 beta-[d-[carboxy-(4-hydroxyphenyl)acetyl]-7alpha-methoxy-3-[[(1-methyl-1h-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-azabicyclo[4.1.0]-oct-2-en-2-carbonsaenrediammoniumsalz Download PDF

Info

Publication number
DD150352A5
DD150352A5 DD80220809A DD22080980A DD150352A5 DD 150352 A5 DD150352 A5 DD 150352A5 DD 80220809 A DD80220809 A DD 80220809A DD 22080980 A DD22080980 A DD 22080980A DD 150352 A5 DD150352 A5 DD 150352A5
Authority
DD
German Democratic Republic
Prior art keywords
epimer
solution
diammonium salt
oxa
item
Prior art date
Application number
DD80220809A
Other languages
German (de)
English (en)
Inventor
Kuo S Yang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DD150352A5 publication Critical patent/DD150352A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD80220809A 1979-05-01 1980-04-30 Verfahren zur herstellung von antibiotikum 7 beta-[d-[carboxy-(4-hydroxyphenyl)acetyl]-7alpha-methoxy-3-[[(1-methyl-1h-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-azabicyclo[4.1.0]-oct-2-en-2-carbonsaenrediammoniumsalz DD150352A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/035,037 US4252953A (en) 1979-05-01 1979-05-01 Antibiotic crystalline epimer

Publications (1)

Publication Number Publication Date
DD150352A5 true DD150352A5 (de) 1981-08-26

Family

ID=21880235

Family Applications (1)

Application Number Title Priority Date Filing Date
DD80220809A DD150352A5 (de) 1979-05-01 1980-04-30 Verfahren zur herstellung von antibiotikum 7 beta-[d-[carboxy-(4-hydroxyphenyl)acetyl]-7alpha-methoxy-3-[[(1-methyl-1h-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-azabicyclo[4.1.0]-oct-2-en-2-carbonsaenrediammoniumsalz

Country Status (34)

Country Link
US (1) US4252953A (es)
EP (1) EP0018811B1 (es)
JP (1) JPS55153788A (es)
KR (1) KR840000078B1 (es)
AR (1) AR230450A1 (es)
AT (1) AT370108B (es)
AU (1) AU538283B2 (es)
BE (1) BE882980A (es)
BG (1) BG34905A3 (es)
CA (1) CA1138867A (es)
CH (1) CH646434A5 (es)
CS (1) CS226013B2 (es)
DD (1) DD150352A5 (es)
DE (1) DE3061751D1 (es)
DK (1) DK177980A (es)
EG (1) EG14719A (es)
ES (1) ES8105316A1 (es)
FI (1) FI801345A (es)
FR (1) FR2455605A1 (es)
GB (1) GB2047707B (es)
GR (1) GR68202B (es)
HU (1) HU184750B (es)
IE (1) IE49775B1 (es)
IL (1) IL59912A (es)
IT (1) IT1141935B (es)
LU (1) LU82411A1 (es)
MY (1) MY8500601A (es)
NZ (1) NZ193528A (es)
PH (1) PH15596A (es)
PL (1) PL125579B1 (es)
PT (1) PT71140A (es)
RO (1) RO79684A (es)
SU (1) SU860705A3 (es)
ZA (1) ZA802475B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597193A (ja) * 1982-07-02 1984-01-14 Shionogi & Co Ltd マロニルメチル基の異性化方法
DE102004049396A1 (de) * 2003-10-08 2005-07-28 Behr Gmbh & Co. Kg Bauteil, insbesondere Hybridträger für ein Fahrzeug, und Verfahren zur Herstellung eines derartigen Bauteils sowie Verwendung eines derartigen Bauteils
US20070057535A1 (en) * 2003-10-08 2007-03-15 Behr Gmbh & Co.Kg Method and device for the production of a component, especially a hybrid component for a crossrail of a vehicle, component and use of said component

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR61146B (en) * 1976-03-25 1978-09-27 Shionogi & Co Preparation process of 1-oxadethiacephalosporins analogues
CA1085392A (en) * 1976-03-25 1980-09-09 Masayuki Narisada Arylmalonamido-1-oxadethiacephalosporins
US4148997A (en) * 1977-11-07 1979-04-10 Yeda Research And Development Co., Ltd. 7-[Sulfomethyl)phenyl]acetamidocephalosporin derivatives
US4124762A (en) * 1977-11-07 1978-11-07 Yeda Research And Development Co., Ltd. 7-[(Pyridylthiomethyl)phenyl]acetamido-cephalosporin derivatives
US4125715A (en) * 1977-11-25 1978-11-14 Yeda Research And Development Co. Ltd. 7-[(Substituted-isothioureamethyl)phenyl]-acetamidocephalosporin derivatives

Also Published As

Publication number Publication date
DE3061751D1 (en) 1983-03-03
IL59912A (en) 1984-02-29
GB2047707A (en) 1980-12-03
KR830002779A (ko) 1983-05-30
AR230450A1 (es) 1984-04-30
FR2455605B1 (es) 1983-05-27
SU860705A3 (ru) 1981-08-30
IT1141935B (it) 1986-10-08
EG14719A (en) 1985-06-30
GR68202B (es) 1981-11-10
PL223753A1 (es) 1981-02-13
AU538283B2 (en) 1984-08-09
IE49775B1 (en) 1985-12-11
PL125579B1 (en) 1983-05-31
AT370108B (de) 1983-03-10
PT71140A (en) 1980-05-01
IT8021697A0 (it) 1980-04-29
MY8500601A (en) 1985-12-31
KR840000078B1 (ko) 1984-02-08
LU82411A1 (fr) 1980-07-31
HU184750B (en) 1984-10-29
ES491085A0 (es) 1981-05-16
JPH0118077B2 (es) 1989-04-03
FR2455605A1 (fr) 1980-11-28
GB2047707B (en) 1983-05-18
CS226013B2 (en) 1984-03-19
ZA802475B (en) 1981-12-30
CH646434A5 (fr) 1984-11-30
DK177980A (da) 1980-11-02
ATA220980A (de) 1982-07-15
PH15596A (en) 1983-02-28
US4252953A (en) 1981-02-24
NZ193528A (en) 1982-03-23
EP0018811A1 (en) 1980-11-12
FI801345A (fi) 1980-11-02
IE800882L (en) 1980-11-01
BE882980A (fr) 1980-10-27
CA1138867A (en) 1983-01-04
BG34905A3 (en) 1983-12-15
AU5791480A (en) 1980-11-06
ES8105316A1 (es) 1981-05-16
EP0018811B1 (en) 1983-01-26
JPS55153788A (en) 1980-11-29
RO79684A (ro) 1982-08-17

Similar Documents

Publication Publication Date Title
DE2332878C2 (de) Salze von Cephalosporinen mit Arginin und Lysin, ihre Herstellung und injizierbare pharmazeutische Zubereitungen
DD215552A5 (de) Verfahren zur herstellung von kristallisierten cephem-saeureadditionssalzen
DE2614669C2 (de) Gamma-kristalline wasserfreie Form von 7-(D-alpha-Formyloxy-alpha-phenylacetamido)-3-(1-methyl-1H-tetrazol-5- ylthiomethyl)-3-cephem-4-natriumcarboxylat und Verfahren zu ihrer Herstellung
EP0280157B1 (de) Kristallisierte Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung
DE2953969C2 (es)
DE2738711C2 (de) Salze des Cefotiams
DD150352A5 (de) Verfahren zur herstellung von antibiotikum 7 beta-[d-[carboxy-(4-hydroxyphenyl)acetyl]-7alpha-methoxy-3-[[(1-methyl-1h-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-azabicyclo[4.1.0]-oct-2-en-2-carbonsaenrediammoniumsalz
AT392643B (de) Verfahren zur herstellung von neuen derivaten der 7-(d-2-amino-2-(4-hydroxyphenyl)-acetamido)-3- ((z)-1-propenyl)ceph-3-em-4-carbonsaeure
DE2036027C3 (de) Pleuromutilin-Derivate und Verfahren zu ihrer Herstellung
DE1143817C2 (de) Verfahren zur Herstellung von 6-Phenoxyacylamidopenicillansaeure-derivaten und von nicht giftigen Salzen derselben
DE2501957C2 (de) Verfahren zur Gewinnung von optisch aktivem p-Hydroxyphenylglycin
DE2736482A1 (de) Salze von derivaten von 6-(1-sulfato-aethyl)-7-oxo-1-azabicyclo eckige klammer auf 3.2.0 eckige klammer zu hept-2-en-2-carbonsaeureestern, verfahren zu ihrer herstellung und diese salze enthaltende arzneipraeparate
EP0181571A1 (de) Kristalline Aminomethyl-Verbindung
DD150205A5 (de) Verfahren zur herstellung des d-sesquinatriumsalzes von beta-[d-[carboxy(4-hydroxyphenyl)acetyl]amino]-7 alpha-methoxy-3-[[(1-methyl-1-h-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-aza-bicyclo-[4.1.0]oct-2-en-carbonsaeure
DE2253801A1 (de) 2-(thiocarbonylamino)acetamidocephalosporansaeureverbindungen
DE3102984A1 (de) Verfahren zur herstellung von cysteamin-s-substituierten verbindungen und deren derivaten
DE1545838C3 (de) 7-(2-Azidooctanamido)-cephalosporansäure, deren Salze und Verfahren zur Herstellung dieser Verbindungen
DE2025415B2 (de) Verfahren zur Herstellung von cyclischen Acylureido-Penicillinen
AT337365B (de) Verfahren zur herstellung von neuen derivaten des cephalosporins und von ihren salzen
DE1620749C3 (de) Verfahren zur Herstellung von Carbothiamin
DE3745094B4 (de) Ein kristallines Hydrat der 7ß-[(Z)-2-(2-Aminothiazol-4-yl)-4-carboxybut-2-enoylamino]-3-cephem-4-carbonsäure enthaltende Hartgelatinekapsel-Zusammensetzung
AT337366B (de) Verfahren zur herstellung von neuen derivaten des cephalosporins und von ihren salzen
DEP0030192DA (de) Verfahren zur Herstellung von Alkalimetallsalzen und Erdalkalimetallsalzen des Penicillins G.
DE1176147B (de) Verfahren zur Herstellung von 7-Aminocephalosporansaeure
DE2445195B2 (de) 9-0-acyl-3''-0-acyloxymethylderivate des antibioticums sf-837 sowie verfahren zur herstellung derselben